Global Synthetic Peptide Vaccine Market Growth 2021-2026


Jul, 2021 | Report ID: 191540 | 118 | Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Synthetic Peptide Vaccine will have significant change from previous year. By the most conservative estimates of global Synthetic Peptide Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Synthetic Peptide Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Peptide Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Solution Phase Synthesis (SPS)

Solid Phase Peptide Synthesis (SPPS)

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Prostate Cancer

Breast Cancer

Gastric Cancer

Lung Cancer

Pancreatic Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Anergis

Antigen Express

Apitope Technology

Artificial Cell Technologies

Benovus Bio

Celgene Corporation

Immatics biotechnologies

Merck

ImmunoCellular Therapeutics

ISA Pharmaceuticals

Lytix Biopharma

Spotlight Innovation

OncoTherapy Science

Peptech

Pharmasyntez

Sumitomo Dainippon Pharma

TapImmune

Targovax


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Synthetic Peptide Vaccine Consumption 2016-2026

2.1.2 Synthetic Peptide Vaccine Consumption CAGR by Region

2.2 Synthetic Peptide Vaccine Segment by Type

2.2.1 Solution Phase Synthesis (SPS)

2.2.2 Solid Phase Peptide Synthesis (SPPS)

2.3 Synthetic Peptide Vaccine Sales by Type

2.3.1 Global Synthetic Peptide Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Synthetic Peptide Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Synthetic Peptide Vaccine Sale Price by Type (2016-2021)

2.4 Synthetic Peptide Vaccine Segment by Application

2.4.1 Prostate Cancer

2.4.2 Breast Cancer

2.4.3 Gastric Cancer

2.4.4 Lung Cancer

2.4.5 Pancreatic Cancer

2.4.6 Others

2.5 Synthetic Peptide Vaccine Sales by Application

2.5.1 Global Synthetic Peptide Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Synthetic Peptide Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Synthetic Peptide Vaccine Sale Price by Application (2016-2021)

3 Global Synthetic Peptide Vaccine by Company

3.1 Global Synthetic Peptide Vaccine Sales Market Share by Company

3.1.1 Global Synthetic Peptide Vaccine Sales by Company (2019-2021)

3.1.2 Global Synthetic Peptide Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Synthetic Peptide Vaccine Revenue Market Share by Company

3.2.1 Global Synthetic Peptide Vaccine Revenue by Company (2019-2021)

3.2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Synthetic Peptide Vaccine Sale Price by Company

3.4 Global Manufacturers Synthetic Peptide Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Synthetic Peptide Vaccine Product Location Distribution

3.4.2 Players Synthetic Peptide Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Synthetic Peptide Vaccine by Region

4.1 Global Synthetic Peptide Vaccine by Region

4.1.1 Global Synthetic Peptide Vaccine Sales by Region

4.1.2 Global Synthetic Peptide Vaccine Revenue by Region

4.2 Americas Synthetic Peptide Vaccine Sales Growth

4.3 APAC Synthetic Peptide Vaccine Sales Growth

4.4 Europe Synthetic Peptide Vaccine Sales Growth

4.5 Middle East & Africa Synthetic Peptide Vaccine Sales Growth

5 Americas

5.1 Americas Synthetic Peptide Vaccine Sales by Country

5.1.1 Americas Synthetic Peptide Vaccine Sales by Country (2016-2021)

5.1.2 Americas Synthetic Peptide Vaccine Revenue by Country (2016-2021)

5.2 Americas Synthetic Peptide Vaccine Sales by Type

5.3 Americas Synthetic Peptide Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Synthetic Peptide Vaccine Sales by Region

6.1.1 APAC Synthetic Peptide Vaccine Sales by Region (2016-2021)

6.1.2 APAC Synthetic Peptide Vaccine Revenue by Region (2016-2021)

6.2 APAC Synthetic Peptide Vaccine Sales by Type

6.3 APAC Synthetic Peptide Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Synthetic Peptide Vaccine by Country

7.1.1 Europe Synthetic Peptide Vaccine Sales by Country (2016-2021)

7.1.2 Europe Synthetic Peptide Vaccine Revenue by Country (2016-2021)

7.2 Europe Synthetic Peptide Vaccine Sales by Type

7.3 Europe Synthetic Peptide Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Synthetic Peptide Vaccine by Country

8.1.1 Middle East & Africa Synthetic Peptide Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Synthetic Peptide Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Synthetic Peptide Vaccine Sales by Type

8.3 Middle East & Africa Synthetic Peptide Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Synthetic Peptide Vaccine Distributors

10.3 Synthetic Peptide Vaccine Customer

11 Global Synthetic Peptide Vaccine Market Forecast

11.1 Global Synthetic Peptide Vaccine Forecast by Region

11.1.1 Global Synthetic Peptide Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Synthetic Peptide Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Synthetic Peptide Vaccine Forecast by Type

11.7 Global Synthetic Peptide Vaccine Forecast by Application

12 Key Players Analysis

12.1 Anergis

12.1.1 Anergis Company Information

12.1.2 Anergis Synthetic Peptide Vaccine Product Offered

12.1.3 Anergis Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Anergis Main Business Overview

12.1.5 Anergis Latest Developments

12.2 Antigen Express

12.2.1 Antigen Express Company Information

12.2.2 Antigen Express Synthetic Peptide Vaccine Product Offered

12.2.3 Antigen Express Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Antigen Express Main Business Overview

12.2.5 Antigen Express Latest Developments

12.3 Apitope Technology

12.3.1 Apitope Technology Company Information

12.3.2 Apitope Technology Synthetic Peptide Vaccine Product Offered

12.3.3 Apitope Technology Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Apitope Technology Main Business Overview

12.3.5 Apitope Technology Latest Developments

12.4 Artificial Cell Technologies

12.4.1 Artificial Cell Technologies Company Information

12.4.2 Artificial Cell Technologies Synthetic Peptide Vaccine Product Offered

12.4.3 Artificial Cell Technologies Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Artificial Cell Technologies Main Business Overview

12.4.5 Artificial Cell Technologies Latest Developments

12.5 Benovus Bio

12.5.1 Benovus Bio Company Information

12.5.2 Benovus Bio Synthetic Peptide Vaccine Product Offered

12.5.3 Benovus Bio Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Benovus Bio Main Business Overview

12.5.5 Benovus Bio Latest Developments

12.6 Celgene Corporation

12.6.1 Celgene Corporation Company Information

12.6.2 Celgene Corporation Synthetic Peptide Vaccine Product Offered

12.6.3 Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Celgene Corporation Main Business Overview

12.6.5 Celgene Corporation Latest Developments

12.7 Immatics biotechnologies

12.7.1 Immatics biotechnologies Company Information

12.7.2 Immatics biotechnologies Synthetic Peptide Vaccine Product Offered

12.7.3 Immatics biotechnologies Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Immatics biotechnologies Main Business Overview

12.7.5 Immatics biotechnologies Latest Developments

12.8 Merck

12.8.1 Merck Company Information

12.8.2 Merck Synthetic Peptide Vaccine Product Offered

12.8.3 Merck Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Merck Main Business Overview

12.8.5 Merck Latest Developments

12.9 ImmunoCellular Therapeutics

12.9.1 ImmunoCellular Therapeutics Company Information

12.9.2 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Offered

12.9.3 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 ImmunoCellular Therapeutics Main Business Overview

12.9.5 ImmunoCellular Therapeutics Latest Developments

12.10 ISA Pharmaceuticals

12.10.1 ISA Pharmaceuticals Company Information

12.10.2 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Offered

12.10.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 ISA Pharmaceuticals Main Business Overview

12.10.5 ISA Pharmaceuticals Latest Developments

12.11 Lytix Biopharma

12.11.1 Lytix Biopharma Company Information

12.11.2 Lytix Biopharma Synthetic Peptide Vaccine Product Offered

12.11.3 Lytix Biopharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Lytix Biopharma Main Business Overview

12.11.5 Lytix Biopharma Latest Developments

12.12 Spotlight Innovation

12.12.1 Spotlight Innovation Company Information

12.12.2 Spotlight Innovation Synthetic Peptide Vaccine Product Offered

12.12.3 Spotlight Innovation Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Spotlight Innovation Main Business Overview

12.12.5 Spotlight Innovation Latest Developments

12.13 OncoTherapy Science

12.13.1 OncoTherapy Science Company Information

12.13.2 OncoTherapy Science Synthetic Peptide Vaccine Product Offered

12.13.3 OncoTherapy Science Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 OncoTherapy Science Main Business Overview

12.13.5 OncoTherapy Science Latest Developments

12.14 Peptech

12.14.1 Peptech Company Information

12.14.2 Peptech Synthetic Peptide Vaccine Product Offered

12.14.3 Peptech Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Peptech Main Business Overview

12.14.5 Peptech Latest Developments

12.15 Pharmasyntez

12.15.1 Pharmasyntez Company Information

12.15.2 Pharmasyntez Synthetic Peptide Vaccine Product Offered

12.15.3 Pharmasyntez Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Pharmasyntez Main Business Overview

12.15.5 Pharmasyntez Latest Developments

12.16 Sumitomo Dainippon Pharma

12.16.1 Sumitomo Dainippon Pharma Company Information

12.16.2 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Offered

12.16.3 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Sumitomo Dainippon Pharma Main Business Overview

12.16.5 Sumitomo Dainippon Pharma Latest Developments

12.17 TapImmune

12.17.1 TapImmune Company Information

12.17.2 TapImmune Synthetic Peptide Vaccine Product Offered

12.17.3 TapImmune Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 TapImmune Main Business Overview

12.17.5 TapImmune Latest Developments

12.18 Targovax

12.18.1 Targovax Company Information

12.18.2 Targovax Synthetic Peptide Vaccine Product Offered

12.18.3 Targovax Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Targovax Main Business Overview

12.18.5 Targovax Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Synthetic Peptide Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Solution Phase Synthesis (SPS)

Table 3. Major Players of Solid Phase Peptide Synthesis (SPPS)

Table 4. Global Synthetic Peptide Vaccine Sales by Type (2016-2021) & (K Units)

Table 5. Global Synthetic Peptide Vaccine Sales Market Share by Type (2016-2021)

Table 6. Global Synthetic Peptide Vaccine Revenue by Type (2016-2021) & ($ million)

Table 7. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2016-2021)

Table 8. Global Synthetic Peptide Vaccine Sale Price by Type (2016-2021)

Table 9. Global Synthetic Peptide Vaccine Sales by Application (2016-2021) & (K Units)

Table 10. Global Synthetic Peptide Vaccine Sales Market Share by Application (2016-2021)

Table 11. Global Synthetic Peptide Vaccine Value by Application (2016-2021)

Table 12. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2016-2021)

Table 13. Global Synthetic Peptide Vaccine Sale Price by Application (2016-2021)

Table 14. Global Synthetic Peptide Vaccine Sales by Company (2019-2021) & (K Units)

Table 15. Global Synthetic Peptide Vaccine Sales Market Share by Company (2019-2021)

Table 16. Global Synthetic Peptide Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Synthetic Peptide Vaccine Revenue Market Share by Company (2019-2021)

Table 18. Global Synthetic Peptide Vaccine Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Synthetic Peptide Vaccine Producing Area Distribution and Sales Area

Table 20. Players Synthetic Peptide Vaccine Products Offered

Table 21. Synthetic Peptide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Synthetic Peptide Vaccine Sales by Region (2016-2021) (K Units)

Table 25. Global Synthetic Peptide Vaccine Sales Market Share by Region (2016-2021)

Table 26. Global Synthetic Peptide Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2016-2021)

Table 28. Americas Synthetic Peptide Vaccine Sales by Country (2016-2021) & (K Units)

Table 29. Americas Synthetic Peptide Vaccine Sales Market Share by Country (2016-2021)

Table 30. Americas Synthetic Peptide Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Synthetic Peptide Vaccine Revenue Market Share by Country (2016-2021)

Table 32. Americas Synthetic Peptide Vaccine Sales by Type (2016-2021) & (K Units)

Table 33. Americas Synthetic Peptide Vaccine Sales Market Share by Type (2016-2021)

Table 34. Americas Synthetic Peptide Vaccine Sales by Application (2016-2021) & (K Units)

Table 35. Americas Synthetic Peptide Vaccine Sales Market Share by Application (2016-2021)

Table 36. APAC Synthetic Peptide Vaccine Sales by Region (2016-2021) & (K Units)

Table 37. APAC Synthetic Peptide Vaccine Sales Market Share by Region (2016-2021)

Table 38. APAC Synthetic Peptide Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Synthetic Peptide Vaccine Revenue Market Share by Region (2016-2021)

Table 40. APAC Synthetic Peptide Vaccine Sales by Type (2016-2021) & (K Units)

Table 41. APAC Synthetic Peptide Vaccine Sales Market Share by Type (2016-2021)

Table 42. APAC Synthetic Peptide Vaccine Sales by Application (2016-2021) & (K Units)

Table 43. APAC Synthetic Peptide Vaccine Sales Market Share by Application (2016-2021)

Table 44. Europe Synthetic Peptide Vaccine Sales by Country (2016-2021) & (K Units)

Table 45. Europe Synthetic Peptide Vaccine Sales Market Share by Country (2016-2021)

Table 46. Europe Synthetic Peptide Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Synthetic Peptide Vaccine Revenue Market Share by Country (2016-2021)

Table 48. Europe Synthetic Peptide Vaccine Sales by Type (2016-2021) & (K Units)

Table 49. Europe Synthetic Peptide Vaccine Sales Market Share by Type (2016-2021)

Table 50. Europe Synthetic Peptide Vaccine Sales by Application (2016-2021) & (K Units)

Table 51. Europe Synthetic Peptide Vaccine Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Synthetic Peptide Vaccine Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Synthetic Peptide Vaccine Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Synthetic Peptide Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Synthetic Peptide Vaccine Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Synthetic Peptide Vaccine Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Synthetic Peptide Vaccine Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Synthetic Peptide Vaccine Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Synthetic Peptide Vaccine Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Synthetic Peptide Vaccine

Table 61. Key Application and Potential Industries of Synthetic Peptide Vaccine

Table 62. Key Challenges of Synthetic Peptide Vaccine

Table 63. Key Trends of Synthetic Peptide Vaccine

Table 64. Synthetic Peptide Vaccine Distributors List

Table 65. Synthetic Peptide Vaccine Customer List

Table 66. Global Synthetic Peptide Vaccine Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Synthetic Peptide Vaccine Consumption Market Forecast by Region

Table 68. Global Synthetic Peptide Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Synthetic Peptide Vaccine Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Synthetic Peptide Vaccine Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Synthetic Peptide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Synthetic Peptide Vaccine Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Synthetic Peptide Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Synthetic Peptide Vaccine Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Synthetic Peptide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Synthetic Peptide Vaccine Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Synthetic Peptide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Synthetic Peptide Vaccine Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Synthetic Peptide Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Synthetic Peptide Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Synthetic Peptide Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Synthetic Peptide Vaccine Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Synthetic Peptide Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Synthetic Peptide Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Synthetic Peptide Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 86. Anergis Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 87. Anergis Synthetic Peptide Vaccine Product Offered

Table 88. Anergis Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Anergis Main Business

Table 90. Anergis Latest Developments

Table 91. Antigen Express Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 92. Antigen Express Synthetic Peptide Vaccine Product Offered

Table 93. Antigen Express Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Antigen Express Main Business

Table 95. Antigen Express Latest Developments

Table 96. Apitope Technology Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 97. Apitope Technology Synthetic Peptide Vaccine Product Offered

Table 98. Apitope Technology Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Apitope Technology Main Business

Table 100. Apitope Technology Latest Developments

Table 101. Artificial Cell Technologies Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 102. Artificial Cell Technologies Synthetic Peptide Vaccine Product Offered

Table 103. Artificial Cell Technologies Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Artificial Cell Technologies Main Business

Table 105. Artificial Cell Technologies Latest Developments

Table 106. Benovus Bio Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 107. Benovus Bio Synthetic Peptide Vaccine Product Offered

Table 108. Benovus Bio Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. Benovus Bio Main Business

Table 110. Benovus Bio Latest Developments

Table 111. Celgene Corporation Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 112. Celgene Corporation Synthetic Peptide Vaccine Product Offered

Table 113. Celgene Corporation Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. Celgene Corporation Main Business

Table 115. Celgene Corporation Latest Developments

Table 116. Immatics biotechnologies Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 117. Immatics biotechnologies Synthetic Peptide Vaccine Product Offered

Table 118. Immatics biotechnologies Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. Immatics biotechnologies Main Business

Table 120. Immatics biotechnologies Latest Developments

Table 121. Merck Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 122. Merck Synthetic Peptide Vaccine Product Offered

Table 123. Merck Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 124. Merck Main Business

Table 125. Merck Latest Developments

Table 126. ImmunoCellular Therapeutics Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 127. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Offered

Table 128. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 129. ImmunoCellular Therapeutics Main Business

Table 130. ImmunoCellular Therapeutics Latest Developments

Table 131. ISA Pharmaceuticals Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 132. ISA Pharmaceuticals Synthetic Peptide Vaccine Product Offered

Table 133. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 134. ISA Pharmaceuticals Main Business

Table 135. ISA Pharmaceuticals Latest Developments

Table 136. Lytix Biopharma Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 137. Lytix Biopharma Synthetic Peptide Vaccine Product Offered

Table 138. Lytix Biopharma Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 139. Lytix Biopharma Main Business

Table 140. Lytix Biopharma Latest Developments

Table 141. Spotlight Innovation Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 142. Spotlight Innovation Synthetic Peptide Vaccine Product Offered

Table 143. Spotlight Innovation Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 144. Spotlight Innovation Main Business

Table 145. Spotlight Innovation Latest Developments

Table 146. OncoTherapy Science Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 147. OncoTherapy Science Synthetic Peptide Vaccine Product Offered

Table 148. OncoTherapy Science Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 149. OncoTherapy Science Main Business

Table 150. OncoTherapy Science Latest Developments

Table 151. Peptech Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 152. Peptech Synthetic Peptide Vaccine Product Offered

Table 153. Peptech Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 154. Peptech Main Business

Table 155. Peptech Latest Developments

Table 156. Pharmasyntez Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 157. Pharmasyntez Synthetic Peptide Vaccine Product Offered

Table 158. Pharmasyntez Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 159. Pharmasyntez Main Business

Table 160. Pharmasyntez Latest Developments

Table 161. Sumitomo Dainippon Pharma Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 162. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Offered

Table 163. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 164. Sumitomo Dainippon Pharma Main Business

Table 165. Sumitomo Dainippon Pharma Latest Developments

Table 166. TapImmune Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 167. TapImmune Synthetic Peptide Vaccine Product Offered

Table 168. TapImmune Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 169. TapImmune Main Business

Table 170. TapImmune Latest Developments

Table 171. Targovax Basic Information, Synthetic Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 172. Targovax Synthetic Peptide Vaccine Product Offered

Table 173. Targovax Synthetic Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 174. Targovax Main Business

Table 175. Targovax Latest Developments

List of Figures

Figure 1. Picture of Synthetic Peptide Vaccine

Figure 2. Synthetic Peptide Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Synthetic Peptide Vaccine Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Synthetic Peptide Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Synthetic Peptide Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Solution Phase Synthesis (SPS)

Figure 10. Product Picture of Solid Phase Peptide Synthesis (SPPS)

Figure 11. Global Synthetic Peptide Vaccine Sales Market Share by Type in 2020

Figure 12. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2016-2021)

Figure 13. Synthetic Peptide Vaccine Consumed in Prostate Cancer

Figure 14. Global Synthetic Peptide Vaccine Market: Prostate Cancer (2016-2021) & (K Units)

Figure 15. Synthetic Peptide Vaccine Consumed in Breast Cancer

Figure 16. Global Synthetic Peptide Vaccine Market: Breast Cancer (2016-2021) & (K Units)

Figure 17. Synthetic Peptide Vaccine Consumed in Gastric Cancer

Figure 18. Global Synthetic Peptide Vaccine Market: Gastric Cancer (2016-2021) & (K Units)

Figure 19. Synthetic Peptide Vaccine Consumed in Lung Cancer

Figure 20. Global Synthetic Peptide Vaccine Market: Lung Cancer (2016-2021) & (K Units)

Figure 21. Synthetic Peptide Vaccine Consumed in Pancreatic Cancer

Figure 22. Global Synthetic Peptide Vaccine Market: Pancreatic Cancer (2016-2021) & (K Units)

Figure 23. Synthetic Peptide Vaccine Consumed in Others

Figure 24. Global Synthetic Peptide Vaccine Market: Others (2016-2021) & (K Units)

Figure 25. Global Synthetic Peptide Vaccine Sales Market Share by Application (2016-2021)

Figure 26. Global Synthetic Peptide Vaccine Revenue Market Share by Application in 2020

Figure 27. Synthetic Peptide Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 28. Global Synthetic Peptide Vaccine Revenue Market Share by Company in 2020

Figure 29. Global Synthetic Peptide Vaccine Sales Market Share by Regions (2016-2021)

Figure 30. Global Synthetic Peptide Vaccine Revenue Market Share by Region in 2020

Figure 31. Americas Synthetic Peptide Vaccine Sales 2016-2021 (K Units)

Figure 32. Americas Synthetic Peptide Vaccine Revenue 2016-2021 ($ Millions)

Figure 33. APAC Synthetic Peptide Vaccine Sales 2016-2021 (K Units)

Figure 34. APAC Synthetic Peptide Vaccine Revenue 2016-2021 ($ Millions)

Figure 35. Europe Synthetic Peptide Vaccine Sales 2016-2021 (K Units)

Figure 36. Europe Synthetic Peptide Vaccine Revenue 2016-2021 ($ Millions)

Figure 37. Middle East & Africa Synthetic Peptide Vaccine Sales 2016-2021 (K Units)

Figure 38. Middle East & Africa Synthetic Peptide Vaccine Revenue 2016-2021 ($ Millions)

Figure 39. Americas Synthetic Peptide Vaccine Sales Market Share by Country in 2020

Figure 40. Americas Synthetic Peptide Vaccine Revenue Market Share by Country in 2020

Figure 41. Americas Synthetic Peptide Vaccine Sales Market Share by Type in 2020

Figure 42. Americas Synthetic Peptide Vaccine Sales Market Share by Application in 2020

Figure 43. United States Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 44. Canada Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 45. Mexico Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Brazil Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. APAC Synthetic Peptide Vaccine Sales Market Share by Region in 2020

Figure 48. APAC Synthetic Peptide Vaccine Revenue Market Share by Regions in 2020

Figure 49. APAC Synthetic Peptide Vaccine Sales Market Share by Type in 2020

Figure 50. APAC Synthetic Peptide Vaccine Sales Market Share by Application in 2020

Figure 51. China Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 52. Japan Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 53. Korea Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 54. Southeast Asia Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 55. India Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. Australia Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. Europe Synthetic Peptide Vaccine Sales Market Share by Country in 2020

Figure 58. Europe Synthetic Peptide Vaccine Revenue Market Share by Country in 2020

Figure 59. Europe Synthetic Peptide Vaccine Sales Market Share by Type in 2020

Figure 60. Europe Synthetic Peptide Vaccine Sales Market Share by Application in 2020

Figure 61. Germany Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 62. France Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 63. UK Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 64. Italy Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. Russia Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. Middle East & Africa Synthetic Peptide Vaccine Sales Market Share by Country in 2020

Figure 67. Middle East & Africa Synthetic Peptide Vaccine Revenue Market Share by Country in 2020

Figure 68. Middle East & Africa Synthetic Peptide Vaccine Sales Market Share by Type in 2020

Figure 69. Middle East & Africa Synthetic Peptide Vaccine Sales Market Share by Application in 2020

Figure 70. Egypt Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 71. South Africa Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 72. Israel Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 73. Turkey Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 74. GCC Country Synthetic Peptide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles

Sample Request is not available